MetaCap

Medline Inc. Class A (MDLN)

NASDAQ: MDLNHealth CareMedical/Dental InstrumentsUSD

37.04-0.80 (-2.11%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MDLN stock chart

Technical analysis

Key statistics

All statistics
Market cap
$48.75B
52-week range
31.37 – 50.88
Day range
36.94 – 38.37
Volume / Avg
9.33M / 9.55M
Beta
—

52-week range

$31.37$50.88

MDLN stock today

Medline (MDLN) closed at $37.04 on Nov 20, down 2.11% (-$0.80), versus the S&P 500's 3.70% decline. Shares are 27.2% below their 52-week high of $50.88, set on Feb 25, 2026 and 18.1% above the 52-week low of $31.37, in the middle of the past year's range. MDLN is down 11.8% year to date, underperforming the S&P 500 (+1.2%).

At 84.2x trailing earnings, Medline trades above the peer-group median of 36.6x. Its forward P/E of 24.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Medline

Company profile

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions.

Industry
Medical/Dental Instruments
CEO
Mr. James M. Boyle
Headquarters
Northfield, IL
Employees
45,000
IPO year
2025

Financial highlights

Full financials

In fiscal 2025, Medline generated $28.43 billion in revenue. Net income was $1.16 billion (+0.5% year over year), for a net margin of 4.1% versus a median of 2.8% in the prior 3 years. Gross margin was 26.4% and operating margin 7.8%.

Medline annual revenue, net income and EPS
Fiscal yearFY 2025FY 2025FY 2024FY 2023
Revenue$28.43B—$25.51B$23.23B
Growth——+9.80%—
Net income$1.16B$1.15B$1.16B$234.00M
EPS (diluted)$-0.01———

Analyst forecast

Forecast

Consensus (25 analysts)

buy

Avg. price target

$45.75+23.52%

  • Strong buy 6
  • Buy 15
  • Hold 4
  • Sell 0
  • Strong sell 0

Target range

Low $34.00High $55.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$0.22 vs $0.32
Surprise
-31.25%

MDLN news

All MDLN news

Medline peers

Health Care sector
MDLN peer companies
CompanyPrice% ChgMarket capCompare
BDXBecton Dickinson and Company212.78+0.05%$57.96Bvs MDLN
BSXBoston Scientific Corporation41.98-2.35%$60.85Bvs MDLN
RMDResMed Inc.235.63-0.53%$33.14Bvs MDLN
DXCMDexCom Inc.79.32-1.08%$29.58Bvs MDLN
WSTWest Pharmaceutical Services Inc.390.30-1.61%$27.19Bvs MDLN
SOLVSolventum Corporation84.50-1.52%$14.36Bvs MDLN
GKOSGlaukos Corporation237.31-0.33%$14.05Bvs MDLN
BAXBaxter International Inc.25.390.00%$13.14Bvs MDLN

Indexes, lists and sector

Medline stock FAQ

What is Medline's stock price today?

MDLN last traded at $37.04 as of Nov 20, 4:00 PM EST, down 2.11% on the day. Prices are delayed at least 15 minutes.

What is MDLN's P/E ratio?

MDLN trades at a trailing P/E ratio of 84.18 and a forward P/E of 23.98, compared with a median of 36.6 for its closest peers.

Who is Medline's CEO?

Mr. James M. Boyle is the chief executive officer of Medline Inc. Class A, which has about 45,000 employees.

What is the MDLN 52-week high?

The 52-week high for MDLN is $50.88 and the 52-week low is $31.37. The stock is currently 27.2% below its high.

Compare MDLN